These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 17408366)

  • 1. Potential of active and passive immunizations for the prevention and therapy of transmissible spongiform encephalopathies.
    Bade S; Frey A
    Expert Rev Vaccines; 2007 Apr; 6(2):153-68. PubMed ID: 17408366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell culture models of transmissible spongiform encephalopathies.
    Béranger F; Mangé A; Solassol J; Lehmann S
    Biochem Biophys Res Commun; 2001 Nov; 289(2):311-6. PubMed ID: 11716473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prion protein-specific antibodies for therapeutic intervention of transmissible spongiform encephalopathies.
    Buchholz CJ; Bach P; Nikles D; Kalinke U
    Expert Opin Biol Ther; 2006 Mar; 6(3):293-300. PubMed ID: 16503737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapeutic effect of anti-PrP monoclonal antibodies in transmissible spongiform encephalopathy mouse models: pharmacokinetic and pharmacodynamic analysis.
    Féraudet-Tarisse C; Andréoletti O; Morel N; Simon S; Lacroux C; Mathey J; Lamourette P; Relaño A; Torres JM; Créminon C; Grassi J
    J Gen Virol; 2010 Jun; 91(Pt 6):1635-45. PubMed ID: 20107012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curative properties of antibodies against prion protein: a comparative in vitro study of monovalent fragments and divalent antibodies.
    Alexandrenne C; Hanoux V; Dkhissi F; Boquet D; Couraud JY; Wijkhuisen A
    J Neuroimmunol; 2009 Apr; 209(1-2):50-6. PubMed ID: 19232746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination with prion peptide-displaying papillomavirus-like particles induces autoantibodies to normal prion protein that interfere with pathologic prion protein production in infected cells.
    Handisurya A; Gilch S; Winter D; Shafti-Keramat S; Maurer D; Schätzl HM; Kirnbauer R
    FEBS J; 2007 Apr; 274(7):1747-58. PubMed ID: 17313482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human and animal spongiform encephalopathies are autoimmune diseases: a novel theory and its supporting evidence.
    Zhu BT
    Int Rev Neurobiol; 2005; 63():155-90. PubMed ID: 15797468
    [No Abstract]   [Full Text] [Related]  

  • 8. Is vaccination against transmissible spongiform encephalopathy feasible?
    Wisniewski T; Chabalgoity JA; Goni F
    Rev Sci Tech; 2007 Apr; 26(1):243-51. PubMed ID: 17633306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent developments in prion immunotherapy.
    Heppner FL; Aguzzi A
    Curr Opin Immunol; 2004 Oct; 16(5):594-8. PubMed ID: 15342005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-prion antibodies for prophylaxis following prion exposure in mice.
    Sigurdsson EM; Sy MS; Li R; Scholtzova H; Kascsak RJ; Kascsak R; Carp R; Meeker HC; Frangione B; Wisniewski T
    Neurosci Lett; 2003 Jan; 336(3):185-7. PubMed ID: 12505623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostics for TSE agents.
    Raeber AJ; Oesch B
    Dev Biol (Basel); 2006; 123():313-23; discussion 349-54. PubMed ID: 16566455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of antibody fragments for immunotherapy of prion diseases.
    Campana V; Zentilin L; Mirabile I; Kranjc A; Casanova P; Giacca M; Prusiner SB; Legname G; Zurzolo C
    Biochem J; 2009 Mar; 418(3):507-15. PubMed ID: 19000036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody F89/160.1.5 defines a conserved epitope on the ruminant prion protein.
    O'Rourke KI; Baszler TV; Miller JM; Spraker TR; Sadler-Riggleman I; Knowles DP
    J Clin Microbiol; 1998 Jun; 36(6):1750-5. PubMed ID: 9620413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination against prion diseases.
    Kalinke U; Bach P; König M; Buchholz CJ
    Discov Med; 2006 Feb; 6(31):29-34. PubMed ID: 17234125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human and animal spongiform encephalopathies are the result of chronic autoimmune attack in the CNS: a novel medical theory supported by overwhelming experimental evidence.
    Zhu BT
    Histol Histopathol; 2005 Apr; 20(2):575-92. PubMed ID: 15736062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy for prion diseases: opportunities and obstacles.
    Li L; Napper S; Cashman NR
    Immunotherapy; 2010 Mar; 2(2):269-82. PubMed ID: 20635933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine approaches to prevent and treat prion infection : progress and challenges.
    Müller-Schiffmann A; Korth C
    BioDrugs; 2008; 22(1):45-52. PubMed ID: 18215090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic approaches targeting the prion receptor LRP/LR.
    Zuber C; Ludewigs H; Weiss S
    Vet Microbiol; 2007 Aug; 123(4):387-93. PubMed ID: 17498894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventional strategies against prion diseases.
    Aguzzi A; Glatzel M; Montrasio F; Prinz M; Heppner FL
    Nat Rev Neurosci; 2001 Oct; 2(10):745-9. PubMed ID: 11584312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prions: protein aggregation and infectious diseases.
    Aguzzi A; Calella AM
    Physiol Rev; 2009 Oct; 89(4):1105-52. PubMed ID: 19789378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.